Cargando…

Public health concerns for anti-obesity medicines imported for personal use through the internet: a cross-sectional study

OBJECTIVE: To explore the circulation of anti-obesity medicines via the internet and their quality. DESIGN: Cross-sectional study. SETTING: Internet pharmacies and pharmaceutical suppliers accessible from Japan. PARTICIPANTS: Anti-obesity medicines were purchased using relevant keywords on Japanese...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Mohiuddin Hussain, Tanimoto, Tsuyoshi, Nakanishi, Yoko, Yoshida, Naoko, Tsuboi, Hirohito, Kimura, Kazuko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Group 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3353131/
https://www.ncbi.nlm.nih.gov/pubmed/22581794
http://dx.doi.org/10.1136/bmjopen-2012-000854
_version_ 1782232997060149248
author Khan, Mohiuddin Hussain
Tanimoto, Tsuyoshi
Nakanishi, Yoko
Yoshida, Naoko
Tsuboi, Hirohito
Kimura, Kazuko
author_facet Khan, Mohiuddin Hussain
Tanimoto, Tsuyoshi
Nakanishi, Yoko
Yoshida, Naoko
Tsuboi, Hirohito
Kimura, Kazuko
author_sort Khan, Mohiuddin Hussain
collection PubMed
description OBJECTIVE: To explore the circulation of anti-obesity medicines via the internet and their quality. DESIGN: Cross-sectional study. SETTING: Internet pharmacies and pharmaceutical suppliers accessible from Japan. PARTICIPANTS: Anti-obesity medicines were purchased using relevant keywords on Japanese Google search engine. Blogs and advertisement-only sites were excluded. PRIMARY AND SECONDARY OUTCOME MEASURES: The authenticity of the samples was investigated in collaboration with the manufacturers of the samples and medicine regulatory authorities. Quality of the samples was assessed by pharmacopoeial analyses using high-performance liquid chromatography. RESULTS: 82 samples were purchased from 36 internet sites. Approximately half of the sites did not mention a physical address, and 45% of the samples did not contain a package insert. A variety of custom declarations were made for the shipments of the samples: personal health items, supplement, medicines, general merchandise, tea and others. Among 82 samples, 52 samples were analysed to check their pharmacopoeial quality. Authenticity responses were received from only five of 20 manufacturing companies. According to the pharmacopoeial analyses and authenticity investigation, three of the samples were identified as counterfeits and did not contain any active ingredients. Two of these samples were confirmed as counterfeits by the manufacturer of the authentic products. The manufacturer of the other sample did not respond to our request for an authenticity check even after several communication attempts. These counterfeit cases have been reported at the rapid alert system of Western Pacific Region of the WHO. CONCLUSIONS: Many counterfeit and unapproved anti-obesity medicines may be easily bypassing regulatory checks during shipping and are widely circulated through the internet. Regulatory authorities should take measures to prevent these medicines from entering countries to safeguard their citizens.
format Online
Article
Text
id pubmed-3353131
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BMJ Group
record_format MEDLINE/PubMed
spelling pubmed-33531312012-05-22 Public health concerns for anti-obesity medicines imported for personal use through the internet: a cross-sectional study Khan, Mohiuddin Hussain Tanimoto, Tsuyoshi Nakanishi, Yoko Yoshida, Naoko Tsuboi, Hirohito Kimura, Kazuko BMJ Open Public Health OBJECTIVE: To explore the circulation of anti-obesity medicines via the internet and their quality. DESIGN: Cross-sectional study. SETTING: Internet pharmacies and pharmaceutical suppliers accessible from Japan. PARTICIPANTS: Anti-obesity medicines were purchased using relevant keywords on Japanese Google search engine. Blogs and advertisement-only sites were excluded. PRIMARY AND SECONDARY OUTCOME MEASURES: The authenticity of the samples was investigated in collaboration with the manufacturers of the samples and medicine regulatory authorities. Quality of the samples was assessed by pharmacopoeial analyses using high-performance liquid chromatography. RESULTS: 82 samples were purchased from 36 internet sites. Approximately half of the sites did not mention a physical address, and 45% of the samples did not contain a package insert. A variety of custom declarations were made for the shipments of the samples: personal health items, supplement, medicines, general merchandise, tea and others. Among 82 samples, 52 samples were analysed to check their pharmacopoeial quality. Authenticity responses were received from only five of 20 manufacturing companies. According to the pharmacopoeial analyses and authenticity investigation, three of the samples were identified as counterfeits and did not contain any active ingredients. Two of these samples were confirmed as counterfeits by the manufacturer of the authentic products. The manufacturer of the other sample did not respond to our request for an authenticity check even after several communication attempts. These counterfeit cases have been reported at the rapid alert system of Western Pacific Region of the WHO. CONCLUSIONS: Many counterfeit and unapproved anti-obesity medicines may be easily bypassing regulatory checks during shipping and are widely circulated through the internet. Regulatory authorities should take measures to prevent these medicines from entering countries to safeguard their citizens. BMJ Group 2012-05-11 /pmc/articles/PMC3353131/ /pubmed/22581794 http://dx.doi.org/10.1136/bmjopen-2012-000854 Text en © 2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode.
spellingShingle Public Health
Khan, Mohiuddin Hussain
Tanimoto, Tsuyoshi
Nakanishi, Yoko
Yoshida, Naoko
Tsuboi, Hirohito
Kimura, Kazuko
Public health concerns for anti-obesity medicines imported for personal use through the internet: a cross-sectional study
title Public health concerns for anti-obesity medicines imported for personal use through the internet: a cross-sectional study
title_full Public health concerns for anti-obesity medicines imported for personal use through the internet: a cross-sectional study
title_fullStr Public health concerns for anti-obesity medicines imported for personal use through the internet: a cross-sectional study
title_full_unstemmed Public health concerns for anti-obesity medicines imported for personal use through the internet: a cross-sectional study
title_short Public health concerns for anti-obesity medicines imported for personal use through the internet: a cross-sectional study
title_sort public health concerns for anti-obesity medicines imported for personal use through the internet: a cross-sectional study
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3353131/
https://www.ncbi.nlm.nih.gov/pubmed/22581794
http://dx.doi.org/10.1136/bmjopen-2012-000854
work_keys_str_mv AT khanmohiuddinhussain publichealthconcernsforantiobesitymedicinesimportedforpersonalusethroughtheinternetacrosssectionalstudy
AT tanimototsuyoshi publichealthconcernsforantiobesitymedicinesimportedforpersonalusethroughtheinternetacrosssectionalstudy
AT nakanishiyoko publichealthconcernsforantiobesitymedicinesimportedforpersonalusethroughtheinternetacrosssectionalstudy
AT yoshidanaoko publichealthconcernsforantiobesitymedicinesimportedforpersonalusethroughtheinternetacrosssectionalstudy
AT tsuboihirohito publichealthconcernsforantiobesitymedicinesimportedforpersonalusethroughtheinternetacrosssectionalstudy
AT kimurakazuko publichealthconcernsforantiobesitymedicinesimportedforpersonalusethroughtheinternetacrosssectionalstudy